Press briefings, by any measure, are long and loud. And now they may get longer and louder since there is another potential antiviral drug to yell about.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
